Akebia Therapeutics announces $50 million public offering of common stock at $2.00

From Nasdaq: 2025-03-20 18:51:05

Akebia Therapeutics prices public offering of 25 million common stock shares at $2.00 each, aiming to raise $50 million before expenses. Underwriters granted option to purchase additional 3.75 million shares. Offering to close on March 21, 2025, subject to conditions. Shares offered under shelf registration statement filed with SEC in September 2024. AKBA closed at $2.04 Thursday, a 28.17% decline, with no change in after-hours trading on Nasdaq Capital Market.



Read more at Nasdaq: Akebia Therapeutics Announces $50 Mln Public Offering Of Common Stock